A new offering, INFAT PRO, features higher levels of sn-2 palmitate, while INFAT MF is a blend containing milk fat. Both new products were unveiled at Food Ingredients Europe, December 3 to 5 in Paris.
Breastfed babies receive many of their nutritional needs from palmitic acid, the most common saturated fatty acid in humans. Between 70 and 80% of the palmitic acid in human milk is attached to the glycerol backbone in the sn-2 position, which facilitates calcium and fat absorption. However, in many oils used in formula, sn-2 concentration is as low as 8 to 10%.
INFAT – Advanced Lipids’ original fat ingredient – already contains around 40 to 45% sn-2 palmitate, enabling formulas to more closely provide many of the benefits of breast milk, the company said.
Dr Marcus Gliwitzki, CEO at Advanced Lipids, said, “INFAT PRO allows formula manufacturers to get even closer to the benefits of breast milk. It offers all the advantages of our original formulation but with even more sn-2 palmitate. This means fat, calcium and other essential nutrients can be better absorbed, supporting infant health and development.”
The other new product on show at Food Ingredients Europe (FIE) is INFAT MF, a blend made with milk fat. Adding lipid components from milk to formula offers natural taste, and together with high sn-2, the product is designed to offer “the best of both worlds,” the company said.
Ronald van der Knaap, chairman of Advanced Lipids, said, “The ‘one-size-fits-all’ approach no longer works in formula markets, where it’s increasingly important for manufacturers to offer consumers a choice. We’ve worked hard to develop these innovative new additions to our range, and we’re delighted to have the chance to showcase them at FIE.”